Skip to main content
GutCited

Fructooligosaccharides (FOS) pour Chronic Constipation

C

Some studies show increased stool frequency. Bifidogenic effect well-established but clinical laxation effect more modest than inulin.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dfructooligosaccharides\u0026condition\u003Dconstipation'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

En conclusion

Some studies show increased stool frequency. Bifidogenic effect well-established but clinical laxation effect more modest than inulin.

Key Study Findings

Review
Prebiotics and Gut Health: Mechanisms, Clinical Evidence, and Future Directions.
Dose: None vs: None Outcome: gut health outcomes including microbiota modulation and SCFA … Effet: None None

Population: healthy individuals, children, elderly, and those with constipation, metabolic syndrome, or dysbiosis

Randomized Controlled Trial n=67 4 weeks Double-blind
Effects and Persistence of Bifidobacterium animalis subsp. lactis BL-99 and Fructooligosaccharides on Older Adults with …
Dose: None vs: Placebo Outcome: Weekly spontaneous bowel movements Effet: 4.94 vs 3.00 (P<0.001) P<0.001

Population: Older adults >=60 with functional constipation (Rome IV)

Other
Maternal or post-weaning dietary fructo-oligosaccharide supplementation reduces stillbirth rate of sows and diarrhea of weaned …
Dose: 2 g vs: None Outcome: Constipation symptoms Effet: None P < 0.05

Population: Constipation patients

Randomized Controlled Trial Double-blind
Xylo-oligosaccharides improve functional constipation by targeted enrichment of Bifidobacterium.
Dose: 6 g vs: Placebo Outcome: Constipation symptoms Effet: None None

Population: Constipation patients

Systematic Review
Fructooligosaccharides for Relieving Functional Constipation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Dose: None vs: None Outcome: Constipation symptoms Effet: OR: 10.36 p < 0.00001

Population: Constipation patients

Randomized Controlled Trial Double-blind
Advice to People with Parkinson's in My Clinic: Probiotics and Prebiotics.
Dose: None vs: Placebo Outcome: Constipation symptoms Effet: None None

Population: Constipation patients

Key Statistics

4

Études

350

Participants

Positive

C

Note

Referenced Papers

Journal of Parkinson's … 2024 4 citations
Journal of physiology … 2009 312 citations
Journal of the … 2007 84 citations
BioFactors (Oxford, England) 2004 48 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Posologies couramment utilisées

general:
2-10 g/day
prebioticeffect:
5-8 g/day for bifidogenic effect
constipationsupport:
5-10 g/day

Limite supérieure : Well-tolerated up to 20 g/day; start low to avoid excess gas

Posologies étudiées dans la recherche

Posologie Durée Effet N
None -- Positive --
None 4 weeks Positive 67
2 g -- Neutral --
6 g -- Positive --
None -- Positive --
None -- Positive --
None -- Mixed --
None -- Positive --

Moment optimal de prise : With meals; divide doses throughout the day

Safety & Side Effects

Effets indésirables signalés

  • Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day)
  • Abdominal cramping at higher doses
  • May worsen IBS symptoms in FODMAP-sensitive individuals
  • Loose stools at excessive doses

Interactions connues

  • Other FODMAPs (cumulative fermentation effect in sensitive individuals)
  • Blood sugar-lowering medications (FOS may modestly affect glycemic response)
  • Calcium supplements (FOS may enhance calcium absorption)

Apport maximal tolérable : Well-tolerated up to 20 g/day; start low to avoid excess gas

Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.

Frequently Asked Questions

Does Fructooligosaccharides (FOS) help with Chronic Constipation?
Based on 4 studies with 350 participants, there is limited but promising evidence that Fructooligosaccharides (FOS) may support Chronic Constipation management. Our evidence grade is C (Some Evidence).
How much Fructooligosaccharides (FOS) should I take for Chronic Constipation?
Studies have used various dosages. A commonly studied range is 2-10 g/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Fructooligosaccharides (FOS)?
Reported side effects may include Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day), Abdominal cramping at higher doses, May worsen IBS symptoms in FODMAP-sensitive individuals, Loose stools at excessive doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Fructooligosaccharides (FOS) and Chronic Constipation?
We rate the evidence as Grade C (Some Evidence). This rating is based on 4 peer-reviewed studies with 350 total participants. The overall direction of effect is positive.

Related Evidence

Autres ingrédients pour Chronic Constipation

Fructooligosaccharides (FOS) pour d'autres pathologies

Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.